FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

36782811000001105: Rupatadine 1mg/ml oral solution (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Mar 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
112689501000001115 Rupatadine 1mg/ml oral solution (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
112689601000001116 Rupatadine 1mg/ml oral solution (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rupatadine 1mg/ml oral solution (Aspire Pharma Ltd) Has specific active ingredient Rupatadine fumarate true Inferred relationship Existential restriction modifier
Rupatadine 1mg/ml oral solution (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rupatadine 1mg/ml oral solution (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rupatadine 1mg/ml oral solution (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rupatadine 1mg/ml oral solution (Aspire Pharma Ltd) Is a Rupatadine 1mg/ml oral solution true Inferred relationship Existential restriction modifier
Rupatadine 1mg/ml oral solution (Aspire Pharma Ltd) Has active ingredient Substance with histamine receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Rupatadine 1mg/ml oral solution (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rupatadine 1mg/ml oral solution (Aspire Pharma Ltd) Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Rupatadine 1mg/ml oral solution (Aspire Pharma Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Rupatadine 1mg/ml oral solution (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rupatadine 1mg/ml oral solution (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rupatadine 1mg/ml oral solution (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rupatadine false Inferred relationship Existential restriction modifier
Rupatadine 1mg/ml oral solution (Aspire Pharma Ltd) Has specific active ingredient Rupatadine fumarate false Inferred relationship Existential restriction modifier
Rupatadine 1mg/ml oral solution (Aspire Pharma Ltd) Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rupatadine 1mg/ml oral solution (Aspire Pharma Ltd) 120 ml Has AMP True Rupatadine 1mg/ml oral solution (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start